EMR

Here's What You May Have Missed About Emerson Electric Company (EMR)

Shares of Technology sector company Emerson Electric Company moved 0.9% today, and are now trading at a price of $89.32. The large-cap stock's daily volume was 659,584 compared to its average volume of 2,961,145. The S&P 500 index returned a 1.0% performance.

Emerson Electric Co., a technology and software company, provides various solutions for customers in industrial, commercial, and consumer markets in the Americas, Asia, the Middle East, Africa, and Europe. The company is based in Saint Louis and has 67,000 full time employees. Its market capitalization is $50,920,247,296. Emerson Electric Company currently offers its equity investors a dividend that yields 2.3% per year.

21 analysts are following Emerson Electric Company and have set target prices ranging from $88.0 to $120.0 per share. On average, they have given the company a rating of buy. At today's prices, EMR is trading -15.93% away from its average analyst target price of $106.24 per share.

Over the last year, EMR shares have gone down by -6.0%, which represents a difference of -21.0% when compared to the S&P 500. The stock's 52 week high is $100.62 per share and its 52 week low is $76.94. Although Emerson Electric Company's average free cash flow over the last 6 years has been $2.43 Billion, they have been decreasing at an average rate of -2.4%. For this reason, investors may continue to shun the stock.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 2,497,000 526,000 1,971,000 -17.57
2022 2,922,000 531,000 2,391,000 -20.14
2021 3,575,000 581,000 2,994,000 17.64
2020 3,083,000 538,000 2,545,000 5.51
2019 3,006,000 594,000 2,412,000 6.02
2018 2,892,000 617,000 2,275,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS